Carlyle Group’s Heartflow Inc HTFL Stock Holding History

Carlyle Group’s Portfolio HTFL Stock Details HTFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,438	Closed	-$497K	–	23
2026 Q1	$497K	Buy	+20,438	New	+$555K	﹤0.01%	16

Other funds holding HTFL

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Carlyle Group's HTFL Position: Q2 2026 in Review

Carlyle Group sold out of Heartflow Inc (HTFL) in Q2 2026, closing a stake of 20,438 shares — an estimated $497K sold.

Carlyle Group first reported a position in HTFL in Q1 2026 and held it in 1 quarter. The position peaked at $497K in Q1 2026. 193 funds tracked by Wall St. Rank hold HTFL as of Q2 2026.

Carlyle Group reported no remaining Heartflow Inc position as of Q2 2026 after selling out during the quarter.
Carlyle Group sold 20,438 Heartflow Inc shares in Q2 2026, an estimated $497K.
Carlyle Group first reported a position in Heartflow Inc in Q1 2026 and held it in 1 quarter.
Carlyle Group's Heartflow Inc position peaked at $497K in Q1 2026.
193 funds tracked by Wall St. Rank held Heartflow Inc as of Q2 2026.

Based on Carlyle Group's 13F filing for Q2 2026, filed 7 Aug 2026.